| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PTEN Phosphohydrolase | 18 | 2015 | 85 | 2.870 |
Why?
|
| Tumor Suppressor Proteins | 11 | 2015 | 204 | 2.120 |
Why?
|
| Glioblastoma | 10 | 2016 | 159 | 1.540 |
Why?
|
| Phosphoric Monoester Hydrolases | 9 | 2006 | 47 | 1.510 |
Why?
|
| Brain Neoplasms | 12 | 2016 | 313 | 1.510 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 4 | 2025 | 17 | 0.910 |
Why?
|
| Dacarbazine | 4 | 2016 | 18 | 0.900 |
Why?
|
| Phosphatidylinositols | 7 | 2025 | 52 | 0.770 |
Why?
|
| ErbB Receptors | 3 | 2024 | 118 | 0.670 |
Why?
|
| Glioma | 5 | 2010 | 100 | 0.640 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 457 | 0.630 |
Why?
|
| Cell Membrane | 5 | 2024 | 501 | 0.600 |
Why?
|
| Stem Cells | 5 | 2004 | 262 | 0.590 |
Why?
|
| Lipid Bilayers | 3 | 2025 | 53 | 0.560 |
Why?
|
| Neurons | 5 | 2003 | 934 | 0.530 |
Why?
|
| Antineoplastic Agents, Alkylating | 3 | 2014 | 34 | 0.520 |
Why?
|
| Epidermal Growth Factor | 5 | 2024 | 47 | 0.510 |
Why?
|
| Phosphatidylinositol Phosphates | 5 | 2024 | 40 | 0.490 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 49 | 0.480 |
Why?
|
| Biophysical Phenomena | 1 | 2015 | 22 | 0.450 |
Why?
|
| Cell Line, Tumor | 11 | 2016 | 1494 | 0.450 |
Why?
|
| Protein Binding | 8 | 2015 | 1619 | 0.410 |
Why?
|
| Signal Transduction | 7 | 2024 | 3068 | 0.410 |
Why?
|
| Animals | 26 | 2024 | 20955 | 0.340 |
Why?
|
| Biomarkers, Tumor | 3 | 2009 | 512 | 0.330 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 77 | 0.320 |
Why?
|
| Mutation | 6 | 2012 | 2633 | 0.310 |
Why?
|
| Mice, Nude | 5 | 2016 | 280 | 0.310 |
Why?
|
| Apoptosis | 7 | 2016 | 1095 | 0.310 |
Why?
|
| Phosphorylation | 7 | 2015 | 948 | 0.300 |
Why?
|
| Cell Division | 4 | 2010 | 455 | 0.300 |
Why?
|
| Membrane Proteins | 4 | 2013 | 908 | 0.290 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 20 | 0.290 |
Why?
|
| Mice | 17 | 2016 | 10994 | 0.290 |
Why?
|
| Autistic Disorder | 1 | 2010 | 147 | 0.280 |
Why?
|
| Neoplastic Stem Cells | 1 | 2009 | 199 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2016 | 195 | 0.270 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 2024 | 5 | 0.270 |
Why?
|
| Unilamellar Liposomes | 2 | 2025 | 9 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2003 | 329 | 0.250 |
Why?
|
| Cell Nucleus | 2 | 2008 | 634 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2014 | 358 | 0.230 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 783 | 0.230 |
Why?
|
| Humans | 29 | 2024 | 64272 | 0.230 |
Why?
|
| Neuropeptides | 1 | 2005 | 81 | 0.230 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 114 | 0.220 |
Why?
|
| Nervous System | 2 | 2004 | 70 | 0.220 |
Why?
|
| Temperature | 2 | 2024 | 312 | 0.220 |
Why?
|
| Cell Proliferation | 5 | 2013 | 1000 | 0.210 |
Why?
|
| Magnesium | 1 | 2024 | 55 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2015 | 106 | 0.210 |
Why?
|
| Cell Movement | 2 | 2005 | 464 | 0.210 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2004 | 74 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2010 | 495 | 0.200 |
Why?
|
| Proteolysis | 1 | 2024 | 149 | 0.200 |
Why?
|
| Schizosaccharomyces | 1 | 2004 | 105 | 0.200 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2003 | 7 | 0.200 |
Why?
|
| Receptor, trkA | 1 | 2003 | 3 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 202 | 0.200 |
Why?
|
| Triazenes | 1 | 2002 | 2 | 0.200 |
Why?
|
| Drug Synergism | 1 | 2003 | 142 | 0.190 |
Why?
|
| Neuroblastoma | 1 | 2003 | 53 | 0.190 |
Why?
|
| Talin | 1 | 2022 | 3 | 0.190 |
Why?
|
| Brain | 3 | 2008 | 1581 | 0.170 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2003 | 224 | 0.170 |
Why?
|
| Cell Differentiation | 6 | 2009 | 1365 | 0.170 |
Why?
|
| Microscopy, Fluorescence | 3 | 2008 | 402 | 0.170 |
Why?
|
| Calcium | 1 | 2024 | 580 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 283 | 0.170 |
Why?
|
| Central Nervous System | 1 | 2003 | 197 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 310 | 0.160 |
Why?
|
| Blotting, Western | 3 | 2008 | 614 | 0.160 |
Why?
|
| Protein Conformation | 4 | 2009 | 785 | 0.150 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 183 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 3 | 2010 | 460 | 0.140 |
Why?
|
| Intermediate Filament Proteins | 3 | 2008 | 19 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2003 | 709 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 785 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2009 | 207 | 0.140 |
Why?
|
| Aniline Compounds | 2 | 2014 | 37 | 0.140 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 705 | 0.130 |
Why?
|
| DNA Primers | 4 | 2011 | 295 | 0.130 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2014 | 24 | 0.130 |
Why?
|
| Cell Survival | 2 | 2013 | 582 | 0.130 |
Why?
|
| Antineoplastic Agents | 3 | 2010 | 667 | 0.130 |
Why?
|
| Hydroxyquinolines | 1 | 2016 | 3 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 3 | 2008 | 429 | 0.120 |
Why?
|
| bcl-X Protein | 1 | 2015 | 23 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2008 | 2138 | 0.120 |
Why?
|
| Molecular Docking Simulation | 1 | 2015 | 80 | 0.110 |
Why?
|
| Endopeptidases | 1 | 2015 | 68 | 0.110 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2014 | 1 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2014 | 3449 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 151 | 0.110 |
Why?
|
| Codon, Initiator | 1 | 2014 | 11 | 0.110 |
Why?
|
| DNA Repair | 1 | 2016 | 250 | 0.110 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 10 | 0.110 |
Why?
|
| Phosphatidylserines | 2 | 2012 | 13 | 0.110 |
Why?
|
| Databases, Protein | 1 | 2014 | 47 | 0.110 |
Why?
|
| Membrane Fluidity | 1 | 2014 | 15 | 0.110 |
Why?
|
| Transfection | 4 | 2015 | 696 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 869 | 0.100 |
Why?
|
| Nestin | 3 | 2008 | 13 | 0.100 |
Why?
|
| Cerebral Ventricles | 2 | 2005 | 29 | 0.100 |
Why?
|
| Benzenesulfonates | 2 | 2010 | 13 | 0.100 |
Why?
|
| Models, Biological | 2 | 2009 | 1187 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2010 | 1552 | 0.100 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2010 | 26 | 0.100 |
Why?
|
| Amino Acids | 1 | 2014 | 148 | 0.100 |
Why?
|
| Glutathione Transferase | 2 | 2003 | 41 | 0.100 |
Why?
|
| DNA, Complementary | 2 | 2010 | 166 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 674 | 0.100 |
Why?
|
| Lipid Metabolism | 2 | 2006 | 223 | 0.100 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2011 | 65 | 0.100 |
Why?
|
| Cholesterol | 1 | 2014 | 260 | 0.100 |
Why?
|
| Pyridines | 2 | 2010 | 114 | 0.090 |
Why?
|
| Cell Lineage | 3 | 2009 | 273 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 432 | 0.090 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 123 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 239 | 0.090 |
Why?
|
| Glycine | 1 | 2011 | 50 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 375 | 0.090 |
Why?
|
| Ethylnitrosourea | 3 | 2006 | 11 | 0.090 |
Why?
|
| Carmustine | 1 | 2010 | 11 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2006 | 901 | 0.080 |
Why?
|
| Binding Sites | 3 | 2015 | 914 | 0.080 |
Why?
|
| Membrane Lipids | 1 | 2010 | 28 | 0.080 |
Why?
|
| Spheroids, Cellular | 1 | 2010 | 27 | 0.080 |
Why?
|
| Mitochondria | 2 | 2011 | 383 | 0.080 |
Why?
|
| Activating Transcription Factors | 1 | 2010 | 11 | 0.080 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 58 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 46 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2010 | 212 | 0.080 |
Why?
|
| Dipeptides | 1 | 2010 | 68 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 240 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2011 | 2177 | 0.080 |
Why?
|
| Receptors, Notch | 1 | 2010 | 106 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 239 | 0.080 |
Why?
|
| Protein Multimerization | 2 | 2024 | 182 | 0.080 |
Why?
|
| Exons | 1 | 2010 | 201 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 174 | 0.080 |
Why?
|
| Culture Media | 1 | 2009 | 79 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 286 | 0.070 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 17 | 0.070 |
Why?
|
| Karyotyping | 1 | 2008 | 47 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 532 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 100 | 0.070 |
Why?
|
| Retroviridae | 1 | 2008 | 74 | 0.070 |
Why?
|
| Integrases | 1 | 2008 | 38 | 0.070 |
Why?
|
| Centrosome | 1 | 2008 | 71 | 0.070 |
Why?
|
| Rats | 4 | 2006 | 2005 | 0.070 |
Why?
|
| Protein Folding | 2 | 2015 | 268 | 0.070 |
Why?
|
| Time Factors | 3 | 2006 | 3725 | 0.070 |
Why?
|
| Male | 5 | 2016 | 30322 | 0.060 |
Why?
|
| Forecasting | 1 | 2007 | 233 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 20 | 0.060 |
Why?
|
| Pregnancy, Animal | 1 | 2006 | 9 | 0.060 |
Why?
|
| Prognosis | 1 | 2010 | 1769 | 0.060 |
Why?
|
| Dentate Gyrus | 1 | 2005 | 13 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 1597 | 0.060 |
Why?
|
| Diffusion | 1 | 2005 | 82 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 150 | 0.060 |
Why?
|
| Bromodeoxyuridine | 2 | 2002 | 44 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2005 | 190 | 0.060 |
Why?
|
| Astrocytes | 1 | 2006 | 121 | 0.060 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2005 | 20 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 1162 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 52 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 279 | 0.060 |
Why?
|
| Cations, Divalent | 1 | 2024 | 23 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2004 | 46 | 0.050 |
Why?
|
| Microtubules | 1 | 2005 | 210 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2005 | 97 | 0.050 |
Why?
|
| Protein Transport | 1 | 2005 | 405 | 0.050 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2004 | 12 | 0.050 |
Why?
|
| Lysosomes | 1 | 2024 | 168 | 0.050 |
Why?
|
| Allosteric Site | 1 | 2003 | 31 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 1297 | 0.050 |
Why?
|
| Ions | 1 | 2003 | 57 | 0.050 |
Why?
|
| Blastocyst | 1 | 2004 | 73 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2003 | 2 | 0.050 |
Why?
|
| Tensins | 1 | 2003 | 1 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2003 | 5 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2003 | 8 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2003 | 27 | 0.050 |
Why?
|
| Neurites | 1 | 2003 | 23 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2003 | 147 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 77 | 0.050 |
Why?
|
| Dithiothreitol | 1 | 2002 | 18 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2003 | 39 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 153 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 58 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2003 | 35 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 197 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2010 | 5696 | 0.050 |
Why?
|
| Phosphates | 1 | 2003 | 93 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 32 | 0.050 |
Why?
|
| Glutathione | 1 | 2002 | 56 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 297 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2003 | 386 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2003 | 112 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2003 | 108 | 0.050 |
Why?
|
| Female | 8 | 2010 | 33383 | 0.050 |
Why?
|
| Catalysis | 1 | 2003 | 164 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2003 | 140 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 248 | 0.050 |
Why?
|
| Olfactory Bulb | 1 | 2002 | 19 | 0.050 |
Why?
|
| Cysteine | 1 | 2002 | 108 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 365 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2003 | 202 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2003 | 112 | 0.050 |
Why?
|
| Cell Separation | 1 | 2002 | 146 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 134 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 324 | 0.050 |
Why?
|
| Caspases | 1 | 2003 | 176 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 458 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2002 | 131 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2003 | 312 | 0.040 |
Why?
|
| Kinetics | 1 | 2003 | 766 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2003 | 668 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 210 | 0.040 |
Why?
|
| Neoplasms | 1 | 2011 | 1393 | 0.040 |
Why?
|
| Niacinamide | 2 | 2010 | 32 | 0.040 |
Why?
|
| Phenylurea Compounds | 2 | 2010 | 31 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2002 | 304 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2010 | 167 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 851 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 446 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2006 | 625 | 0.040 |
Why?
|
| Cell Line | 2 | 2015 | 2057 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1999 | 0.040 |
Why?
|
| Autophagy | 2 | 2010 | 231 | 0.030 |
Why?
|
| Pregnancy | 4 | 2006 | 2370 | 0.030 |
Why?
|
| Scattering, Small Angle | 1 | 2015 | 17 | 0.030 |
Why?
|
| Base Sequence | 2 | 2011 | 1335 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2015 | 62 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 18 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 86 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2014 | 6 | 0.030 |
Why?
|
| DNA Modification Methylases | 1 | 2014 | 18 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 43 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 260 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 2014 | 37 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 490 | 0.030 |
Why?
|
| Indazoles | 1 | 2014 | 17 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 436 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 386 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 517 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2002 | 1541 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2006 | 158 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2014 | 142 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2014 | 131 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 320 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 396 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 289 | 0.020 |
Why?
|
| Neutrons | 1 | 2012 | 2 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 35 | 0.020 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 12 | 0.020 |
Why?
|
| Guanidines | 1 | 2011 | 13 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2011 | 28 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 374 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 31 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 209 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 2237 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2015 | 718 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2010 | 12 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 205 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 68 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 201 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 141 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 106 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2011 | 196 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 471 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 544 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 189 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 417 | 0.020 |
Why?
|
| Tryptophan | 1 | 2008 | 56 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 621 | 0.020 |
Why?
|
| Osteopontin | 1 | 2006 | 21 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2005 | 13 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 929 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 267 | 0.010 |
Why?
|
| Gliosis | 1 | 2004 | 28 | 0.010 |
Why?
|
| Carcinogens | 1 | 2004 | 36 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 41 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 2004 | 41 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2004 | 130 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 519 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 171 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 260 | 0.010 |
Why?
|
| Antimetabolites | 1 | 2002 | 18 | 0.010 |
Why?
|
| Clone Cells | 1 | 2002 | 116 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2004 | 142 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 1174 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 891 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 1431 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 14663 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 17136 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 17923 | 0.010 |
Why?
|